CA2945759C - Methods and devices for isolating lead 203 - Google Patents

Methods and devices for isolating lead 203 Download PDF

Info

Publication number
CA2945759C
CA2945759C CA2945759A CA2945759A CA2945759C CA 2945759 C CA2945759 C CA 2945759C CA 2945759 A CA2945759 A CA 2945759A CA 2945759 A CA2945759 A CA 2945759A CA 2945759 C CA2945759 C CA 2945759C
Authority
CA
Canada
Prior art keywords
composition
column
sodium hydroxide
solution
mci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2945759A
Other languages
English (en)
French (fr)
Other versions
CA2945759A1 (en
Inventor
Keith R. Olewine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
Lantheus Medical Imaging Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantheus Medical Imaging Inc filed Critical Lantheus Medical Imaging Inc
Publication of CA2945759A1 publication Critical patent/CA2945759A1/en
Application granted granted Critical
Publication of CA2945759C publication Critical patent/CA2945759C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F9/00—Treating radioactively contaminated material; Decontamination arrangements therefor
    • G21F9/007—Recovery of isotopes from radioactive waste, e.g. fission products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B13/00—Obtaining lead
    • C22B13/04—Obtaining lead by wet processes
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G21G2001/0094—Other isotopes not provided for in the groups listed above

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2945759A 2014-04-15 2015-04-15 Methods and devices for isolating lead 203 Active CA2945759C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461979957P 2014-04-15 2014-04-15
US61/979,957 2014-04-15
PCT/US2015/026015 WO2015160981A1 (en) 2014-04-15 2015-04-15 Methods and devices for isolating lead 203

Publications (2)

Publication Number Publication Date
CA2945759A1 CA2945759A1 (en) 2015-10-22
CA2945759C true CA2945759C (en) 2023-03-28

Family

ID=54324550

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2945759A Active CA2945759C (en) 2014-04-15 2015-04-15 Methods and devices for isolating lead 203

Country Status (7)

Country Link
US (2) US10199130B2 (https=)
EP (1) EP3131908B1 (https=)
JP (2) JP6920060B2 (https=)
AU (1) AU2015247689B2 (https=)
CA (1) CA2945759C (https=)
ES (1) ES2900325T3 (https=)
WO (1) WO2015160981A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110693076A (zh) * 2019-08-07 2020-01-17 常德华馥生物技术有限公司 降低烟草浸膏中Pb和As含量的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011307A (en) * 1976-06-03 1977-03-08 The United States Of America As Represented By The United States Energy Research And Development Administration Production of 203 Pb-tris-hydroxymethyl amino methane
EP0979513A4 (en) * 1996-08-26 2002-04-10 Arch Dev Corp METHOD AND DEVICE FOR EMPTYING Bi-212 AND USE THEREOF
FR2990956B1 (fr) 2012-05-24 2014-07-04 Areva Med Sas Procede et appareil pour la production de plomb 212 a usage medical

Also Published As

Publication number Publication date
JP6920060B2 (ja) 2021-08-18
US20190131025A1 (en) 2019-05-02
US10199130B2 (en) 2019-02-05
ES2900325T3 (es) 2022-03-16
AU2015247689A1 (en) 2016-11-03
WO2015160981A1 (en) 2015-10-22
EP3131908B1 (en) 2021-09-22
US10910123B2 (en) 2021-02-02
CA2945759A1 (en) 2015-10-22
JP2021165738A (ja) 2021-10-14
AU2015247689B2 (en) 2019-10-10
EP3131908A1 (en) 2017-02-22
US20170040074A1 (en) 2017-02-09
EP3131908A4 (en) 2018-01-17
JP7225305B2 (ja) 2023-02-20
JP2017518867A (ja) 2017-07-13

Similar Documents

Publication Publication Date Title
Alliot et al. Cyclotron production of high purity 44m, 44Sc with deuterons from 44CaCO3 targets
Talip et al. A step-by-step guide for the novel radiometal production for medical applications: case studies with 68Ga, 44Sc, 177Lu and 161Tb
Radchenko et al. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes
US9951399B2 (en) Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target
Bartoś et al. New separation method of no-carrier-added 47Sc from titanium targets
US5409677A (en) Process for separating a radionuclide from solution
Perron et al. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories
Jalilian et al. IAEA activities on 67Cu, 186Re, 47Sc theranostic radionuclides and radiopharmaceuticals
Muenze et al. The Fission‐Based 99Mo Production Process ROMOL‐99 and Its Application to PINSTECH Islamabad
Andersson et al. Robust high-yield~ 1 TBq production of cyclotron based sodium [99mTc] pertechnetate
Park et al. Lu-177 preparation for radiotherapy application
Gizawy et al. Production and radiochemical separation of Tb-161 as a feasible beta therapeutic radioisotope from reactor irradiated Gd target
Kazakov et al. Separation of 89Zr from irradiated yttrium targets by extraction chromatography
US10910123B2 (en) Methods and devices for isolating lead 203
Vosoughi et al. Production of no-carrier-added Ho-166 for targeted therapy purposes
Das et al. Preparation and evaluation of SnO2-based 68Ge/68Ga generator made from 68Ge produced through natZn (α, xn) reaction
Fan et al. Highly selective separation of medical isotope 99mTc from irradiated 100Mo target using PEG-based resins
Koźmiński et al. A semi-automated module for the separation and purification of 99mTc from simulated molybdenum target
Fonseca et al. GMP-automated purification of copper-61 produced in cyclotron liquid targets: Methodological aspects
Ambul et al. Flowsheet Testing for Separation of Lutetium-177 from an Irradiated Ytterbium Target
Dybczyński 50 Years of adventures with neutron activation analysis with the special emphasis on radiochemical separations
Ruiz Quiros A Chromatographic Method to Separate Sc (III) from Zn (II) Ions: A Step in the Purification of Sc-44 (an isotope of medical interest)
Gundu Venkata Surya et al. Purification of 89Sr from FBTR irradiated Yttria target by extraction chromatography using HDEHP impregnated XAD-7 resin
Huclier-Markai et al. Improved titanium-44 purification process for establishing a high apparent molar activity titanium-44/scandium-44 generator
Watanabe et al. Chelating ion-exchange methods for the preparation of no-carrier-added 64Cu

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200324

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250407

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250407